Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles
Congenital disorders of glycosylation (CDG), inherited metabolic diseases caused by defects in glycosylation, are characterized by a high frequency of intellectual disability (ID) and various clinical manifestations. Two siblings with ID, dysmorphic features, and epilepsy were examined using mass sp...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8762ed4b28945f98a16c4990c2bea59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d8762ed4b28945f98a16c4990c2bea59 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d8762ed4b28945f98a16c4990c2bea592021-11-25T17:11:40ZSiblings with MAN1B1-CDG Showing Novel Biochemical Profiles10.3390/cells101131172073-4409https://doaj.org/article/d8762ed4b28945f98a16c4990c2bea592021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3117https://doaj.org/toc/2073-4409Congenital disorders of glycosylation (CDG), inherited metabolic diseases caused by defects in glycosylation, are characterized by a high frequency of intellectual disability (ID) and various clinical manifestations. Two siblings with ID, dysmorphic features, and epilepsy were examined using mass spectrometry of serum transferrin, which revealed a CDG type 2 pattern. Whole-exome sequencing showed that both patients were homozygous for a novel pathogenic variant of <i>MAN1B1</i> (NM_016219.4:c.1837del) inherited from their healthy parents. We conducted a HPLC analysis of sialylated N-linked glycans released from total plasma proteins and characterized the α1,2-mannosidase I activity of the lymphocyte microsome fraction. The accumulation of monosialoglycans was observed in MAN1B1-deficient patients, indicating N-glycan-processing defects. The enzymatic activity of MAN1B1 was compromised in patient-derived lymphocytes. The present patients exhibited unique manifestations including early-onset epileptic encephalopathy and cerebral infarction. They also showed coagulation abnormalities and hypertransaminasemia. Neither sibling had truncal obesity, which is one of the characteristic features of MAN1B1-CDG.Nobuhiko OkamotoTatsuyuki OhtoTakashi EnokizonoYoshinao WadaTomohiro KohmotoIssei ImotoYoshimi HagaJunichi SeinoTadashi SuzukiMDPI AGarticleMAN1B1intellectual disabilitycongenital disorders of glycosylationearly-onset epileptic encephalopathymass spectrometryBiology (General)QH301-705.5ENCells, Vol 10, Iss 3117, p 3117 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
MAN1B1 intellectual disability congenital disorders of glycosylation early-onset epileptic encephalopathy mass spectrometry Biology (General) QH301-705.5 |
spellingShingle |
MAN1B1 intellectual disability congenital disorders of glycosylation early-onset epileptic encephalopathy mass spectrometry Biology (General) QH301-705.5 Nobuhiko Okamoto Tatsuyuki Ohto Takashi Enokizono Yoshinao Wada Tomohiro Kohmoto Issei Imoto Yoshimi Haga Junichi Seino Tadashi Suzuki Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles |
description |
Congenital disorders of glycosylation (CDG), inherited metabolic diseases caused by defects in glycosylation, are characterized by a high frequency of intellectual disability (ID) and various clinical manifestations. Two siblings with ID, dysmorphic features, and epilepsy were examined using mass spectrometry of serum transferrin, which revealed a CDG type 2 pattern. Whole-exome sequencing showed that both patients were homozygous for a novel pathogenic variant of <i>MAN1B1</i> (NM_016219.4:c.1837del) inherited from their healthy parents. We conducted a HPLC analysis of sialylated N-linked glycans released from total plasma proteins and characterized the α1,2-mannosidase I activity of the lymphocyte microsome fraction. The accumulation of monosialoglycans was observed in MAN1B1-deficient patients, indicating N-glycan-processing defects. The enzymatic activity of MAN1B1 was compromised in patient-derived lymphocytes. The present patients exhibited unique manifestations including early-onset epileptic encephalopathy and cerebral infarction. They also showed coagulation abnormalities and hypertransaminasemia. Neither sibling had truncal obesity, which is one of the characteristic features of MAN1B1-CDG. |
format |
article |
author |
Nobuhiko Okamoto Tatsuyuki Ohto Takashi Enokizono Yoshinao Wada Tomohiro Kohmoto Issei Imoto Yoshimi Haga Junichi Seino Tadashi Suzuki |
author_facet |
Nobuhiko Okamoto Tatsuyuki Ohto Takashi Enokizono Yoshinao Wada Tomohiro Kohmoto Issei Imoto Yoshimi Haga Junichi Seino Tadashi Suzuki |
author_sort |
Nobuhiko Okamoto |
title |
Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles |
title_short |
Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles |
title_full |
Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles |
title_fullStr |
Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles |
title_full_unstemmed |
Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles |
title_sort |
siblings with man1b1-cdg showing novel biochemical profiles |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d8762ed4b28945f98a16c4990c2bea59 |
work_keys_str_mv |
AT nobuhikookamoto siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT tatsuyukiohto siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT takashienokizono siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT yoshinaowada siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT tomohirokohmoto siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT isseiimoto siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT yoshimihaga siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT junichiseino siblingswithman1b1cdgshowingnovelbiochemicalprofiles AT tadashisuzuki siblingswithman1b1cdgshowingnovelbiochemicalprofiles |
_version_ |
1718412682538778624 |